Michael W N Deininger

34PUBLICATIONS
141CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursAllergyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 24, 2026
Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.

|Jul 20, 2026
Single agent selinexor is active in patients with myelofibrosis refractory or intolerant to JAK inhibitors.

|Jul 16, 2026
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.

|Jan 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Jason Gotlib, Andreas Reiter, Deepti H Radia

|Jul 11, 2025
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Jane F Apperley, Dragana Milojkovic, Nicholas C P Cross

|Apr 03, 2025
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial.

Fieke W Hoff, Ying Huang, Rina Li Welkie

Pageof 6

Frequent Collaborators

9 joint publications

Jorge E Cortes

8 joint publications

Daniel J DeAngelo

6 joint publications

Michael Mauro

6 joint publications

Brian J Druker